Physician

Laura Elizabeth Rivers, MD

According to 2025 Medicare claims, Laura Rivers, MD (NPI: 1861984437) practices rheumatology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is LAFAYETTE ARTHRITIS AND ENDOCRINE CLINIC APMC (NPI: 1578513149; TIN: 721427672) and primary practice location at 70506-6768. Rivers is affiliated with the Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Rivers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 269 traditional Medicare patients, billed 14,265 HCPCS/CPT codes, and received $137,756 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,031 prescription claims across 195 beneficiaries totaling $262,370 in drug costs, led by Methotrexate (Methotrexate Sodium). Open Payments data shows 71 records totaling $1,850. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,608 to $262,370. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$69K$138K2023 Medicare payment: $34,077 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $137,756 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023752,856$34,077
202426914,265$137,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$200K$400K2018 Drug cost: $2,608 (USD; Tot_Drug_Cst)2019 Drug cost: $29,853 (USD; Tot_Drug_Cst)2020 Drug cost: $7,573 (USD; Tot_Drug_Cst)2021 Drug cost: $59,681 (USD; Tot_Drug_Cst)2022 Drug cost: $399,981 (USD; Tot_Drug_Cst)2023 Drug cost: $316,536 (USD; Tot_Drug_Cst)2024 Drug cost: $262,370 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181545$2,608
201955191$29,853
202041115$7,573
202146162$59,681
202245292$399,981
202383351$316,536
20241951,031$262,370

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more174174$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more203376$89
36415Insertion of needle into vein for collection of blood sample197349$9
86140Measurement c-reactive protein for detection of infection or inflammation174254$5
85652Red blood cell sedimentation rate, to detect inflammation, automated166247$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MethotrexateMethotrexate Sodium1917,804$4,640
LeflunomideLeflunomide904,483$4,474
Hydroxychloroquine SulfateHydroxychloroquine Sulfate1174,348$3,237
Mycophenolate MofetilMycophenolate Mofetil391,440$2,117
PrednisonePrednisone1915,943$1,332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.71$1,850Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Laura Elizabeth Rivers, MD?

Tedicare shows public-source Medicare data for Laura Elizabeth Rivers, MD (NPI 1861984437), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Elizabeth Rivers, MD have ACO affiliation data?

Laura Elizabeth Rivers, MD is shown with ACO affiliation data for Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Laura Elizabeth Rivers, MD?

Laura Elizabeth Rivers, MD is linked to LAFAYETTE ARTHRITIS AND ENDOCRINE CLINIC APMC (billing NPI 1578513149) in the available physician profile data.

Does Laura Elizabeth Rivers, MD have Open Payments data?

Laura Elizabeth Rivers, MD has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.